Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Revealed
India's Third Giant Leap

This Could be One of the Biggest Opportunities for Investors




Important: We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
By submitting your email address, you also sign up for Profit Hunter, a daily newsletter from Equitymaster
covering exciting investing ideas and opportunities in India.

AD

VIKAS LIFECARE 2023-24 Annual Report Analysis
Thu, 17 Oct

VIKAS LIFECARE has announced its results for the year ended March 2024. Let us have a look at the detailed performance review of the company during FY23-24.

VIKAS LIFECARE Income Statement Analysis

  • Operating income during the year fell 12.5% on a year-on-year (YoY) basis.
  • The company's operating profit was by NA YoY during the fiscal. Operating profit margins witnessed a fall and down at 0.6% in FY24 as against 4.2% in FY23.
  • Depreciation charges increased by 5.4% and finance costs increased by 3.2% YoY, respectively.
  • Other income grew by 574.9% YoY.
  • Net profit for the year declined by NA YoY.
  • Net profit margins during the year grew from 3.3% in FY23 to 4.6% in FY24.

VIKAS LIFECARE Income Statement 2023-24

No. of Mths Year Ending 12 Mar-23* 12 Mar-24* % Change
Net Sales Rs m 4,760 4,167 -12.5%
Other income Rs m 39 262 574.9%
Total Revenues Rs m 4,799 4,429 -7.7%
Gross profit Rs m -199 26 NA
Depreciation Rs m 30 32 5.4%
Interest Rs m 23 24 3.2%
Profit before tax Rs m -214 232 NA
Tax Rs m -59 39 NA
Profit after tax Rs m -155 193 NA
Gross profit margin % -4.2 0.6
Effective tax rate % 27.4 16.9
Net profit margin % -3.3 4.6
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



Don't Miss: Key Information for Long-term Investors

VIKAS LIFECARE Balance Sheet Analysis

  • The company's current liabilities during FY24 down at Rs 337 million as compared to Rs 1 billion in FY23, thereby witnessing an decrease of -68.6%.
  • Long-term debt stood at Rs 177 million as compared to Rs 96 million during FY23, a growth of 85.2%.
  • Current assets rose 4% and stood at Rs 2 billion, while fixed assets rose 37% and stood at Rs 3 billion in FY24.
  • Overall, the total assets and liabilities for FY24 stood at Rs 5 billion as against Rs 5 billion during FY23, thereby witnessing a growth of 18%.

VIKAS LIFECARE Balance Sheet as on March 2024

No. of Mths Year Ending 12 Mar-23* 12 Mar-24* % Change
Networth Rs m 3,313 4,608 39.1
 
Current Liabilities Rs m 1,073 337 -68.6
Long-term Debt Rs m 96 177 85.2
Total Liabilities Rs m 4,551 5,381 18.2
 
Current assets Rs m 2,155 2,233 3.6
Fixed Assets Rs m 2,269 3,109 37.0
Total Assets Rs m 4,551 5,381 18.2
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



VIKAS LIFECARE Cash Flow Statement Analysis

  • VIKAS LIFECARE's cash flow from operating activities (CFO) during FY24 stood at Rs -515 million on a YoY basis.
  • Cash flow from investing activities (CFI) during FY24 stood at Rs -819 million, an improvement of 123.6% on a YoY basis.
  • Cash flow from financial activities (CFF) during FY24 stood at Rs 1 billion on a YoY basis.
  • Overall, net cash flows for the company during FY24 stood at Rs 42 million from the Rs 19 million net cash flows seen during FY23.

VIKAS LIFECARE Cash Flow Statement 2023-24

Particulars No. of months 12 12 % Change
Year Ending Mar-23 Mar-24
Cash Flow from Operating Activities Rs m -1,122 -515 -
Cash Flow from Investing Activities Rs m -366 -819 -
Cash Flow from Financing Activities Rs m 1,506 1,376 -8.6%
Net Cash Flow Rs m 19 42 118.2%
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



Current Valuations for VIKAS LIFECARE

  • The trailing twelve-month earnings per share (EPS) of the company stands at Rs 0.1, an improvement from the EPS of Rs -0.1 recorded last year.
  • The price to earnings (P/E) ratio, at the current price of Rs 4.8, stands at -1,323.1 times its trailing twelve months earnings.
  • The price to book value (P/BV) ratio at current price levels stands at 1.9 times, while the price to sales ratio stands at 1.9 times.
  • The company's price to cash flow (P/CF) ratio stood at 38.9 times its end-of-year operating cash flow earnings.

Per Share Data/Valuations

No. of Mths Year Ending 12 Mar-23* 12 Mar-24*
Sales per share (Unadj.) Rs 3.3 2.5
TTM Earnings per share Rs -0.1 0.1
Diluted earnings per share Rs -0.1 0.1
Price to Cash Flow x -49.6 38.9
TTM P/E ratio x -39.9 -1,323.1
Price / Book Value ratio x 2.2 1.9
Market Cap Rs m 7,235 8,741
Dividends per share (Unadj.) Rs 0.0 0.0
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



Ratio Analysis for VIKAS LIFECARE

  • Solvency Ratios
  • Current Ratio: The company's current ratio improved and stood at 6.6x during FY24, from 2.0x during FY23. The current ratio measures the company's ability to pay short-term and long-term obligations.

    Interest Coverage Ratio: The company's interest coverage ratio improved and stood at 10.8x during FY24, from -8.3x during FY23. The interest coverage ratio of a company states how easily a company can pay its interest expense on outstanding debt. A higher ratio is preferable.

  • Profitability Ratios
  • Return on Equity (ROE): The ROE for the company improved and stood at 4.2% during FY24, from -4.7% during FY24. The ROE measures the ability of a firm to generate profits from its shareholders capital in the company.

    Return on Capital Employed (ROCE): The ROCE for the company improved and stood at 5.4% during FY24, from -5.6% during FY23. The ROCE measures the ability of a firm to generate profits from its total capital (shareholder capital plus debt capital) employed in the company.

    Return on Assets (ROA): The ROA of the company improved and stood at 4.0% during FY24, from -2.9% during FY23. The ROA measures how efficiently the company uses its assets to generate earnings.

Key Ratio Analysis

No. of Mths Year Ending 12 Mar-23* 12 Mar-24*
Current ratio x 2.0 6.6
Debtors’ Days Days 1,299 1,213
Interest coverage x -8.3 10.8
Debt to equity ratio x 0.0 0.0
Return on assets % -2.9 4.0
Return on equity % -4.7 4.2
Return on capital employed % -5.6 5.4
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



To see how VIKAS LIFECARE has performed over the last 5 years, please visit here.

VIKAS LIFECARE Share Price Performance

Over the last one year, VIKAS LIFECARE share price has moved down from Rs 5.1 to Rs 4.8, registering a loss of Rs 0.3 or around 5.5%.

Meanwhile, the S&P BSE OIL & GAS Index is trading at Rs 30,024.4 (down 0.6%). Over the last one year it has moved up from 19,153.1 to 30,024.4, a gain of 10,871 points (up 56.8%).

Overall, the S&P BSE SENSEX is up 22.7% over the year.

(To know more, check out historical annual results for VIKAS LIFECARE and quarterly results for VIKAS LIFECARE)

Annual Report FAQs

What is the current share price of VIKAS LIFECARE?

VIKAS LIFECARE currently trades at Rs 4.2 per share. You can check out the latest share price performance of VIKAS LIFECARE here...

What was the revenue of VIKAS LIFECARE in FY24? How does it compare to earlier years?

The revenues of VIKAS LIFECARE stood at Rs 4,429 m in FY24, which was down -7.7% compared to Rs 4,799 m reported in FY23.

VIKAS LIFECARE's revenue has grown from Rs 1,583 m in FY20 to Rs 4,429 m in FY24.

Over the past 5 years, the revenue of VIKAS LIFECARE has grown at a CAGR of 29.3%.

What was the net profit of VIKAS LIFECARE in FY24? How does it compare to earlier years?

The net profit of VIKAS LIFECARE stood at Rs 193 m in FY24, which was NA compared to Rs -155 m reported in FY23.

This compares to a net profit of Rs 289 m in FY22 and a net loss of Rs -35 m in FY21.

Over the past 5 years, VIKAS LIFECARE net profit has grown at a CAGR of 92.9%.

What does the cash flow statement of VIKAS LIFECARE reveal?

The cash flow statement is the financial statement that presents the cash inflows and outflows of a company during a given period of time.

This statement is one of the most useful tools for judging a company's liquidity position. The ratios and parameters in this statement helps test a company's financial health.

The cash flow statement of VIKAS LIFECARE reveals:

  • Cash flow from operations increased in FY24 and stood at Rs -515 m as compared to Rs -1,122 m in FY23.
  • Cash flow from investments decreased in FY24 and stood at Rs -819 m as compared to Rs -366 m in FY23.
  • Cash flow from financial activity decreased in FY24 and stood at Rs 1,376 m as compared to Rs 1,506 m in FY23.

Here's the cash flow statement of VIKAS LIFECARE for the past 5 years.

(Rs m)FY20FY21FY22FY23FY24
From Operations35-77-149-1,122-515
From Investments-11119-385-366-819
From Financial Activity-37-435911,5061,376
Net Cashflow-130751942

What does the Key Ratio analysis of VIKAS LIFECARE reveal?

Be it the company's profitability, operations effectiveness or utilization of funds, ratio analysis is an important tool which helps in making investment decisions.

The ratio/financial analysis of VIKAS LIFECARE reveals:

  • Operating profit margins witnessed a fall and down at 0.6% in FY24 as against 4.2% in FY23.
  • Net profit margins grew from 3.3% in FY23 to 4.6% in FY24.
  • Debt to Equity ratio for FY24 stood at 0.0 as compared to 0.0 in FY23.

Here's the ratio/financial analysis of VIKAS LIFECARE for the past 5 years.

 FY20FY21FY22FY23FY24
Operating Profit Margin (%)3.94.7-0.3-4.20.6
Net Profit Margin (%)0.9-4.79.6-3.34.6
Debt to Equity Ratio (x)0.10.20.00.00.0

Equitymaster requests your view! Post a comment on "VIKAS LIFECARE 2023-24 Annual Report Analysis". Click here!